Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy.

Siraj AK, Kumar Parvathareddy S, Pratheeshkumar P, Padmaja Divya S, Ahmed SO, Melosantos R, Begum R, Concepcion RMJA, Al-Sanea N, Ashari LH, Abduljabbar A, Al-Dayel F, Al-Kuraya KS.

Biomed Pharmacother. 2020 Jan;121:109572. doi: 10.1016/j.biopha.2019.109572. Epub 2019 Nov 5.

2.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Ali Hamidieh A, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas M, Ahmed SO, Novitsky N, Srivastava A, Seber A, Elsolh H, Ghavamzadeh A, Confer D, Kodera Y, Greinix H, Szer J, Horowitz M, Niederwieser D.

Hematol Oncol Stem Cell Ther. 2019 Aug 20. pii: S1658-3876(19)30055-X. doi: 10.1016/j.hemonc.2019.08.002. [Epub ahead of print]

3.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J.

Hematol Oncol Stem Cell Ther. 2019 Aug 20. pii: S1658-3876(19)30054-8. doi: 10.1016/j.hemonc.2019.08.001. [Epub ahead of print]

4.

Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.

Hanbali A, Kotb A, El Fakih R, Alfraih F, Ahmed SO, Shaheen M, Hashmi S, Alhayli S, Alahmari A, Riash MA, Rasheed W, Alzahrani H, Alsharif F, Chaudhri N, Almohareb F, Aljurf M.

Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):670-677. doi: 10.1016/j.clml.2019.05.004. Epub 2019 May 16.

PMID:
31377206
5.

Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19-21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Harif M, Weisdorf D, Novitzky N, Szer J, Mahmal L, Benakli M, Ben Othman T, Bazuaye N, McGrath E, Eldridge PW, Torjemane L, Madani A, Ahmed Nacer R, Belkhedim R, Rasheed W, Ahmed SO, Kodera Y, Aljurf M, Niederwieser DW, Quessar A.

Hematol Oncol Stem Cell Ther. 2019 Jun 4. pii: S1658-3876(19)30048-2. doi: 10.1016/j.hemonc.2019.05.003. [Epub ahead of print]

6.

Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update.

Battipaglia G, Massoud R, Ahmed SO, Legrand O, El Cheikh J, Youniss R, Aljurf M, Mohty M, Bazarbachi A.

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):506-508. doi: 10.1016/j.clml.2019.04.004. Epub 2019 Apr 18.

PMID:
31122828
7.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.

Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale GA, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J.

Biol Blood Marrow Transplant. 2019 May 6. pii: S1083-8791(19)30286-1. doi: 10.1016/j.bbmt.2019.05.002. [Epub ahead of print]

8.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.

Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30235-6. doi: 10.1016/j.bbmt.2019.04.012. [Epub ahead of print] Review.

9.

New approach to differentiate primary from latent Toxoplasma gondii abortion through immunoglobulin and DNA interpretation.

Barakat AMA, Ahmed SO, Zaki MS, El Fadaly HA, Abd El-Razik KA, El-Hariri HM, Johar D.

Microb Pathog. 2018 Dec;125:66-71. doi: 10.1016/j.micpath.2018.09.001. Epub 2018 Sep 3.

PMID:
30189233
10.

Cross-sectional study for determining the prevalence of Q fever in small ruminants and humans at El Minya Governorate, Egypt.

Abushahba MFN, Abdelbaset AE, Rawy MS, Ahmed SO.

BMC Res Notes. 2017 Oct 30;10(1):538. doi: 10.1186/s13104-017-2868-2.

11.

Spatiotemporal interpolation of air pollutants in the Greater Cairo and the Delta, Egypt.

Ahmed SO, Mazloum R, Abou-Ali H.

Environ Res. 2018 Jan;160:27-34. doi: 10.1016/j.envres.2017.09.005. Epub 2017 Sep 21.

PMID:
28941801
12.

Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.

Battipaglia G, Ruggeri A, Massoud R, El Cheikh J, Jestin M, Antar A, Ahmed SO, Rasheed W, Shaheen M, Belhocine R, Brissot E, Dulery R, Eder S, Giannotti F, Isnard F, Lapusan S, Rubio MT, Vekhoff A, Aljurf M, Legrand O, Mohty M, Bazarbachi A.

Cancer. 2017 Aug 1;123(15):2867-2874. doi: 10.1002/cncr.30680. Epub 2017 Apr 7.

13.

FLT3 Inhibitors for Treating Acute Myeloid Leukemia.

Hassanein M, Almahayni MH, Ahmed SO, Gaballa S, El Fakih R.

Clin Lymphoma Myeloma Leuk. 2016 Oct;16(10):543-549. doi: 10.1016/j.clml.2016.06.002. Epub 2016 Jun 25. Review.

PMID:
27450971
14.

Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients.

Alaiya AA, Aljurf M, Shinwari Z, Almohareb F, Malhan H, Alzahrani H, Owaidah T, Fox J, Alsharif F, Mohamed SY, Rasheed W, Aldawsari G, Hanbali A, Ahmed SO, Chaudhri N.

Int J Oncol. 2016 Sep;49(3):913-33. doi: 10.3892/ijo.2016.3618. Epub 2016 Jul 7.

15.

Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.

Alhuraiji A, Alzahrani H, Al Mohareb F, Chaudhri N, Alsharif F, Mohamed S, Rasheed W, Aldawsari G, Ahmed SO, Aljurf M.

Exp Clin Transplant. 2016 Dec;14(6):660-664. doi: 10.6002/ect.2015.0364. Epub 2016 Jul 22.

16.

Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).

Aljurf M, Nassar A, Hamidieh AA, Elhaddad A, Hamladji RM, Bazarbachi A, Ibrahim A, Ben Othman T, Abdel-Rahman F, Alseraihy A, Fahmy O, Hussein AA, Alabdulaaly A, Adil S, Alkindi SS, Bayoumy M, Dennison D, Bekadja MA, Redhouane AN, Rasheed W, AlSagheir A, Alsudairy R, Ladeb S, Benchekroun S, Ramzi M, Ahmed P, ElSolh H, Ahmed SO, Hussain F, Ghavamzadeh A.

Hematol Oncol Stem Cell Ther. 2015 Dec;8(4):167-75. doi: 10.1016/j.hemonc.2015.09.002. Epub 2015 Oct 1.

17.

THPO-MPL pathway and bone marrow failure.

Dasouki M, Saadi I, Ahmed SO.

Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):6-9. doi: 10.1016/j.hemonc.2014.11.005. Epub 2014 Nov 29.

18.

Introduction of vincristine mini-bags and an assessment of the subsequent risk of extravasation.

Nurgat ZA, Smythe M, Al-Jedai A, Ewing S, Rasheed W, Belgaumi A, Ahmed SO, Ashour M, Al Agil A, Siddiqui K, Aljurf M.

J Oncol Pharm Pract. 2015 Oct;21(5):339-47. doi: 10.1177/1078155214531803. Epub 2014 May 12.

PMID:
24821691
19.

Leukemia during pregnancy: long term follow up of 32 cases from a single institution.

Saleh AJ, Alhejazi A, Ahmed SO, Al Mohareb F, AlSharif F, AlZahrani H, Mohamed SY, Rasheed W, AlDawsari G, Ibrahim K, Ahmed S, Chebbo W, ElGohary G, Almahayni M, Chaudhri N, Aljurf M.

Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):63-8. doi: 10.1016/j.hemonc.2014.03.001. Epub 2014 May 9.

20.

Nutritional quality of grains of sorghum cultivar grown under different levels of micronutrients fertilization.

Ahmed SO, Abdalla AW, Inoue T, Ping A, Babiker EE.

Food Chem. 2014 Sep 15;159:374-80. doi: 10.1016/j.foodchem.2014.03.033. Epub 2014 Mar 17.

PMID:
24767069
21.

High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.

Ahmed M, Hussain AR, Bavi P, Ahmed SO, Al Sobhi SS, Al-Dayel F, Uddin S, Al-Kuraya KS.

Carcinogenesis. 2014 Jul;35(7):1564-72. doi: 10.1093/carcin/bgu051. Epub 2014 Feb 28.

PMID:
24583924
22.

Cystic fibrosis in Sudanese children: First report of 35 cases.

Ibrahim SA, Fadl Elmola MA, Karrar ZA, Arabi AM, Abdullah MA, Ali SK, Elawad F, Ali TE, Abdulrahman MB, Ahmed SO, Gundi AS.

Sudan J Paediatr. 2014;14(1):39-44.

23.

Biological Pathotyping of Newcastle Disease Viruses in Sudan 2008-2013.

Bilal ES, Elnasri IM, Alhassan AM, Khalifa KA, Elhag JI, Ahmed SO.

J Vet Med. 2014;2014:209357. doi: 10.1155/2014/209357. Epub 2014 Nov 26.

24.

The role of hematopoietic SCT in adult Burkitt lymphoma.

Ahmed SO, Sureda A, Aljurf M.

Bone Marrow Transplant. 2013 May;48(5):617-29. doi: 10.1038/bmt.2012.129. Epub 2012 Jul 30. Review.

PMID:
22858508
25.

Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia.

Bakr M, Rasheed W, Mohamed SY, Al-Mohareb F, Chaudhri N, Al-Sharif F, Al-Zahrani H, Al-Dawsari G, Saleh AJ, Nassar A, Ahmed S, Elghazaly A, Ahmed SO, Ibrahim K, Chebbo W, El Gohary GM, Al Mahayni MH, Hussain F, Nurgat Z, Elhassan TA, Walter CU, Aljurf M.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1897-904. doi: 10.1016/j.bbmt.2012.07.011. Epub 2012 Jul 21.

26.

Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.

Hussain AR, Ahmed SO, Ahmed M, Khan OS, Al Abdulmohsen S, Platanias LC, Al-Kuraya KS, Uddin S.

PLoS One. 2012;7(6):e39945. doi: 10.1371/journal.pone.0039945. Epub 2012 Jun 29. Erratum in: PLoS One. 2014;9(3):e92484.

27.

Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.

Hussain AR, Uddin S, Bu R, Khan OS, Ahmed SO, Ahmed M, Al-Kuraya KS.

PLoS One. 2011;6(9):e24703. doi: 10.1371/journal.pone.0024703. Epub 2011 Sep 12.

28.

Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.

Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M.

Biol Blood Marrow Transplant. 2011 Sep;17(9):1352-61. doi: 10.1016/j.bbmt.2011.01.019. Epub 2011 Apr 1.

29.

MLL gene in maternal and infantile acute lymphoblastic leukemia and the effect of estrogen.

Aljurf M, Saleh AJ, Ahmed SO.

Leuk Res. 2011 Jul;35(7):e127. doi: 10.1016/j.leukres.2011.02.013. Epub 2011 Mar 10. No abstract available.

PMID:
21396712
30.

Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.

Hussain AR, Uddin S, Ahmed M, Bu R, Ahmed SO, Abubaker J, Sultana M, Ajarim D, Al-Dayel F, Bavi PP, Al-Kuraya KS.

J Pathol. 2010 Oct;222(2):180-90. doi: 10.1002/path.2747.

PMID:
20632385
31.

Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma.

Uddin S, Hussain AR, Ahmed M, Bu R, Ahmed SO, Ajarim D, Al-Dayel F, Bavi P, Al-Kuraya KS.

Mol Cancer Ther. 2010 May;9(5):1244-55. doi: 10.1158/1535-7163.MCT-09-1061. Epub 2010 Apr 27.

32.

Maternal acute lymphoctic leukemia with rearrangement of the mixed lineage leukemia gene occurring during pregnancy.

Aljurf M, Nassar A, Saleh AJ, Almhareb F, Alzahrani H, Walter C, Bakr M, Ahmed SO, Chaudhri N.

Hematol Oncol Stem Cell Ther. 2009;2(3):399-402.

33.

Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells.

Hussain AR, Khan AS, Ahmed SO, Ahmed M, Platanias LC, Al-Kuraya KS, Uddin S.

Cell Prolif. 2010 Apr;43(2):170-83. doi: 10.1111/j.1365-2184.2009.00662.x. Epub 2010 Jan 14.

PMID:
20074295
34.

A postal survey of doctors' attitudes to becoming mentally ill.

Hassan TM, Ahmed SO, White AC, Galbraith N.

Clin Med (Lond). 2009 Aug;9(4):327-32.

35.

Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells.

Hussain AR, Ahmed M, Ahmed SO, Al-Thari S, Khan AS, Razack S, Platanias LC, Al-Kuraya KS, Uddin S.

Leuk Lymphoma. 2009 Jul;50(7):1204-13. doi: 10.1080/10428190902951799.

PMID:
19557642
36.

Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation.

Tabbara KF, Nassar A, Ahmed SO, Al Mohareb F, Aljurf M.

Am J Ophthalmol. 2008 Sep;146(3):462-5. doi: 10.1016/j.ajo.2008.05.012. Epub 2008 Jul 9.

PMID:
18614131
37.

Toxicity and IGR effect of two new neem products against Aedes aegypti (PCSIR strain).

Naqvi SN, Ahmed SO, Mohammad FA.

Pak J Pharm Sci. 1991 Jan;4(1):71-6.

PMID:
16414684

Supplemental Content

Loading ...
Support Center